Skip to main content

Table 3 Odds ratio and corresponding 95%CI for HPV types in dual-stain positive compared to dual-stain negative cases and in HIV positive compared to HIV negative cases, (* significant)

From: Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16INK4a/Ki-67 dual stain cytology in Western Kenya

  Dual-stain cytology HIV status
HPV 16 * 13.6 (95%CI 4.8–38.6) 0,7 (95%CI 0.2–2.3)
HPV 18 * 26.1 (95%CI 5.8–115.9) 1.2 (95%CI 0.15–9.95)
HPV 31 *8.1 (95%CI 2.1–30.8) *3 (95%CI 1.1–8.5)
HPV 33 5,6 (95%CI 0.66–48) *5.1 (95%CI 1.2–20.8)
HPV 35 4.1 (95%CI 0.9–19.1) *5.1 (95%CI 2.1–12.4)
HPV 39 < 0.00 3.8 (95%CI 0.99–14.7)
HPV 45 4.3 (95%CI 0.92–20.1) 2,7 (95%CI 0.97–7.5)
HPV 51 2,1 (95%CI 0.3–16.7) *3 (95%CI 1.1–8.5)
HPV 52 2.6 (95%CI 0.6–11.18) *2.4 (95%CI 1.03–5.8)
HPV 56 < 0.00 < 0.00
HPV 58 *6.6 (95%CI 1.8–24.9) 2 (95%CI 0.7–6)
HPV 59 < 0.00 *4.3 (95%CI 1.1–17.2)
HPV 68 *8 (95%CI 2.7–29.2) 2.3 (95%CI 0.8–6.3)